Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Receivables (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 13 years of Change in Receivables data on record, last reported at -$3.2 million in Q4 2025.

  • For Q4 2025, Change in Receivables fell 11.22% year-over-year to -$3.2 million; the TTM value through Dec 2025 reached $6.4 million, down 70.62%, while the annual FY2025 figure was $6.4 million, 70.62% down from the prior year.
  • Change in Receivables reached -$3.2 million in Q4 2025 per AMPH's latest filing, down from $13.8 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $23.2 million in Q1 2024 and bottomed at -$12.3 million in Q2 2025.
  • Average Change in Receivables over 5 years is $4.0 million, with a median of $4.3 million recorded in 2021.
  • Peak YoY movement for Change in Receivables: soared 1430.46% in 2022, then plummeted 428.82% in 2024.
  • A 5-year view of Change in Receivables shows it stood at $755000.0 in 2021, then skyrocketed by 1430.46% to $11.6 million in 2022, then tumbled by 135.39% to -$4.1 million in 2023, then grew by 28.93% to -$2.9 million in 2024, then fell by 11.22% to -$3.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$3.2 million in Q4 2025, $13.8 million in Q3 2025, and -$12.3 million in Q2 2025.